An expanded NTD list for PLOS Neglected Tropical Diseases

At PLOS Neglected Tropical Diseases, the editors highly support the WHO list but also recognize that the community of NTD investigators conduct research and public health efforts on an expanded group of conditions that still qualify as NTDs due to evidence that they constitute chronic and debilitating conditions disproportionately affecting populations living in extreme poverty [3]. Table 1 lists the NTDs currently recognized by PLOS Neglected Tropical Diseases compared to those recognized by the WHO.

Among the helminth infections, PLOS Neglected Tropical Diseases largely considers just about any helminthic disease of humans. In some cases, we even consider important veterinary helminthiases if they are linked to human zoonotic disease. In our scope, we specifically mention some important conditions that are not included in the WHO list, including loiasis, strongyloidiasis, and toxocariasis (and other larva migrans syndromes), which represent prevalent, high disease burden, human illnesses.

For protozoan infections, we include some key intestinal infections including amebiasis, babesiosis, giardiasis, and others. PLOS Neglected Tropical Diseases, along with the WHO and some other international agencies, does not consider Plasmodium falciparum malaria to be an NTD. Nevertheless, PLOS Neglected Tropical Diseases recognizes that P. vivax and other non-P. falciparum malarias—classically non-fatal but debilitating tropical infections–are understudied relative to falciparum malaria. Therefore, we consider and publish papers on non-falciparum malaria.

For bacterial diseases, the PLOS Neglected Tropical Diseases list is notable for adding cholera and other enteric diarrheal pathogens not considered as NTDs by the WHO, in addition to bartonellosis, bovine tuberculosis, leptospirosis, melioidosis, relapsing fever and Q fever, each an important disease in resource-poor regions. While we consider yaws and other tropical treponematoses as NTDs, we are not ordinarily reviewing or publishing syphilis papers unless there are unusual or specific circumstances to justify this.

For viral infections, we consider just about all arbovirus infections if they affect low- and middle-income countries, in addition to Ebola and other viral hemorrhagic fevers, as well as rabies. We now also consider enterovirus 71 or some of the enterovirus infections, as well as HTLV-1 and HTLV-2 infections, if they specially relate to resource-poor countries. Both the WHO and PLOS Neglected Tropical Diseases lists include ectoparasitic infestations, especially scabies. We also consider two non-infectious conditions–podoconiosis and snakebite envenoming.

Beyond these NTDs, PLOS Neglected Tropical Diseases also considers the important nutritional links underlying NTDs, and co-infections between NTDs and HIV/AIDS, malaria, and tuberculosis. We are also enthusiastic about publishing on the social sciences or public policy if these aspects pertain to neglected diseases.

Other infections “NTDs on the cusp”

We also wish to highlight here some of our more thought-provoking, interesting, and polemical ongoing discussions regarding specific conditions and diseases, especially some that are most debated in terms of whether they truly represent NTDs. Factoring into deliberations and decisions on whether to include a specific disease or condition within the scope of PLOS Neglected Tropical Diseases is the availability of disease burden estimates for that specific condition, and if that burden occurs in resource-poor settings. Delays in accepting submissions in some topics may reflect a lack of editorial expertise to appropriately review and handle such papers, but we will strive to acquire that expertise in order to serve the needs of our community.

Regarding protozoan infections, emerging evidence from the Global Enteric Multicenter Study (GEMS) clearly implicates cryptosporidiosis as an important NTD, especially of young children. Therefore, PLOS Neglected Tropical Diseases will add this disease to our list [4]. However, the journal is less interested in cryptosporidiosis outbreaks in North America and Europe due to direct water contamination unrelated to poverty. Similarly, toxoplasmosis is traditionally considered a disease of North America and Europe, but an evidence base is building for high rates of disease transmission in Africa and Latin America. For that reason, toxoplasmosis as it pertains to low-resource countries would be considered relevant. Blastocystiasis is a disease caused by an organism with an unusual phylogeny, and there is controversy whether it constitutes an actual pathogen. However, we have an interest in these discussions and are willing to consider papers on this topic.

For bacterial infections, we currently consider those diseases that disproportionately affect impoverished populations. Relative to the WHO list, adding relapsing fever, leptospirosis, bartonellosis, cholera, and melioidosis to the PLOS Neglected Tropical Diseases list was a relatively straightforward decision because of their global public health impact. However, adding Salmonella, Shigella, and other enteric bacterial infections occurred with the understanding that we would focus on topical papers relevant to the disease-endemic countries of poverty. We now receive occasional correspondence regarding group A streptococcus and its importance in the pathogenesis of rheumatic fever, glomerulonephritis, and other conditions of the tropics. Given that scabies is a major predisposing factor to streptococcal infections and disease sequelae, increasingly we are willing to consider papers on this topic. Deep fungal infections are now a prominent component of the PLOS Neglected Tropical Diseases papers. We are also willing to consider papers on cryptococcosis and histoplasmosis if they specifically pertain to disease in the setting of extreme poverty.

For viral infections, the scope of PLOS Neglected Tropical Diseases is already larger relative to the WHO list, especially for arboviral infections. We agree that some zoonotic viruses, such as henipaviruses that include Nipah and Hendra viruses, represent emerging tropical disease pathogens, and we are working to expand our editorial expertise to handle and review these papers. At present, we are willing to consider papers on these topics on a case-by-case basis.

Finally, we recognize that sickle cell anemia in many respects resembles an NTD in its clinical and epidemiologic features. We have published a thoughtful editorial making the case why sickle cell anemia might be considered as an NTD [5]. At this time, however, there are already several eminent hematology journals better equipped to review papers on this topic.

Ultimately, the editors at PLOS Neglected Tropical Diseases are open to new ideas and articles about diseases not on the current list. Please note that NTDs are not rare diseases, and therefore rare diseases are beyond the scope of this journal.

Final comment

PLOS Neglected Tropical Diseases is a community journal, and in that context, it is important for the editors to be responsive to the NTD scientific community regarding our current and future scope. We very much look forward to hearing from you about our current topics and expertise, and whether there are new directions we should consider. As such, we encourage prospective authors to send us a viewpoint or propose an editorial article to make a case that an additional disease, illness, or condition qualifies as an NTD. These articles are generally well received, are impactful and can serve to drive the field forward. In this spirit, we would also like to emphasize that PLOS Neglected Tropical Diseases focuses on human disease, not infections that only afflict livestock and other animals unless these diseases also impact human health and represent a public health problem. Further, we would like to reiterate that the focus of our journal is on translational or epidemiological studies, and less so on pure, basic molecular research not associated to improvement of human health.

The scope of PLOS Neglected Tropical Diseases will always be dynamic. We plan to revisit the scope of the journal every five years or so. Once the editorial board arrives at a consensus that an infection or condition qualifies as an NTD, we will strive to bring onboard new expertise to ensure that all NTDs find a home at PLOS Neglected Tropical Diseases.